Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | What to expect in breast cancer in 2021

Cynthia X. Ma, MD, PhD, Washington University School of Medicine in St. Louis, St. Louis, MO, outlines key developments in the treatment of breast cancer expected in 2021, including the use of immune checkpoint inhibitors in the neoadjuvant setting of patients with triple negative breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).


Dr. Ma reports funding from Pfizer, Puma.

Dr. Ma reports consulting and advisory for Novartis, Bayer, Eisai, Athenex, OncoSignal, Seattle Genetics, Eli Lilly.